These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24593233)

  • 1. Impact of mitotic activity on the pathological substaging of pT1 cutaneous melanoma.
    de Waal AC; van Harten-Gerritsen AS; Aben KK; Kiemeney LA; van Rossum MM; Blokx WA
    Br J Dermatol; 2014 Apr; 170(4):874-7. PubMed ID: 24593233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How staging of thin melanoma is changed after the introduction of TNM 7th edition: a population-based analysis.
    Caldarella A; Fancelli L; Manneschi G; Chiarugi A; Nardini P; Crocetti E
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):73-6. PubMed ID: 26113451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of the 7th edition AJCC staging system: Effects on staging and survival for pT1 melanoma. A Dutch population based study.
    Oude Ophuis CM; Louwman MW; Grünhagen DJ; Verhoef K; van Akkooi AC
    Int J Cancer; 2017 Apr; 140(8):1802-1808. PubMed ID: 28109000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved stratification of pT1 melanoma according to the 8th American Joint Committee on Cancer staging edition criteria: A Dutch population-based study.
    Verver D; Louwman WJ; Koljenović S; Verhoef C; Grünhagen DJ; van Akkooi ACJ
    Eur J Cancer; 2018 Mar; 92():100-107. PubMed ID: 29217356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value and prognostic significance of mitotic rate in a retrospective series of pT1 cutaneous malignant melanoma patients.
    Ponti G; Pollio A; Cesinaro AM; Pellacani G; Magnoni C; Seidenari S
    Cancer Epidemiol; 2012 Jun; 36(3):303-5. PubMed ID: 22153914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel node biopsy should be offered in thin melanoma with mitotic rate greater than one.
    Sekula-Gibbs SA; Shearer MA
    Dermatol Surg; 2011 Aug; 37(8):1080-8. PubMed ID: 21635622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mitosis in early invasive malignant melanoma. How reliable is histogenetic classification at stage pT1?].
    Bösmüller H; Haitchi-Petnehazy S; Hintringer T; Mentzel T
    Pathologe; 2012 Mar; 33(2):113-7. PubMed ID: 21845361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is it Necessary to Perform Sentinel Lymph Node Biopsy in Thin Melanoma? A Retrospective Single Center Analysis.
    Kocsis A; Karsko L; Kurgyis Z; Besenyi Z; Pavics L; Dosa-Racz E; Kis E; Baltas E; Ocsai H; Varga E; Bende B; Varga A; Mohos G; Korom I; Varga J; Kemeny L; Nemeth IB; Olah J
    Pathol Oncol Res; 2020 Jul; 26(3):1861-1868. PubMed ID: 31792874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel node biopsy improves prognostic stratification in patients with thin (pT1) melanomas and an additional risk factor.
    Mitteldorf C; Bertsch HP; Jung K; Thoms KM; Schön MP; Tronnier M; Kretschmer L
    Ann Surg Oncol; 2014 Jul; 21(7):2252-8. PubMed ID: 24652352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. American Joint Committee on Cancer clinical stage as a selection criterion for sentinel lymph node biopsy in thin melanoma.
    Vaquerano J; Kraybill WG; Driscoll DL; Cheney R; Kane JM
    Ann Surg Oncol; 2006 Feb; 13(2):198-204. PubMed ID: 16418885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Melanoma Nodal Positivity and Biopsy Rates Before and After Implementation of the 7th Edition of the AJCC Cancer Staging Manual.
    Isom C; Wheless L; Hooks MA; Kauffmann RM
    JAMA Dermatol; 2019 May; 155(5):572-577. PubMed ID: 30840034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitotic rate as a predictive factor for positive sentinel lymph nodes in pT1 and pT2 melanomas.
    Fidanzi C; Bevilacqua M; D'Erme AM; Morganti R; Viacava P; Manzo Margiotta F; Romanelli M; Dini V; Janowska A; Bagnoni G
    J Plast Reconstr Aesthet Surg; 2023 Aug; 83():215-220. PubMed ID: 37279633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of mitosis ≥2 in selecting patients with T1 cutaneous melanomas for sentinel lymph node biopsy.
    Borgognoni L; Crocetti E; Sestini S; Brandani P; Giannotti V; Gerlini G
    Melanoma Res; 2022 Dec; 32(6):469-476. PubMed ID: 36317389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic analysis of 66 Japanese thin melanomas with metastasis of sentinel or regional lymph node.
    Mori M; Sugiura M; Kono M; Matsumoto T; Sawada M; Yokota K; Yasue S; Shibata S; Sakakibara A; Nakamura S; Tomita Y; Akiyama M
    J Cutan Pathol; 2013 Dec; 40(12):1027-34. PubMed ID: 24111935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
    Marghoob AA; Koenig K; Bittencourt FV; Kopf AW; Bart RS
    Cancer; 2000 Feb; 88(3):589-95. PubMed ID: 10649252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitotic rate in cutaneous melanomas ≤1 mm in thickness: a prospective study.
    Litzner BR; Etufugh CN; Stepenaskie S; Hynan LS; Cockerell CJ
    Am J Dermatopathol; 2012 Dec; 34(8):827-32. PubMed ID: 22878366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitotic rate for thin melanomas: should a single mitotic figure warrant a sentinel lymph node biopsy?
    Kirkland EB; Zitelli JA
    Dermatol Surg; 2014 Sep; 40(9):937-45. PubMed ID: 25072127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the 2009 (7th edition) AJCC melanoma staging system in the classification of thin cutaneous melanomas.
    Chu VH; Tetzlaff MT; Torres-Cabala CA; Prieto VG; Bassett R; Gershenwald JE; McLemore MS; Ivan D; Wang WL; Ross MI; Curry JL
    Biomed Res Int; 2013; 2013():898719. PubMed ID: 24369020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of the 2009 American Joint Committee on Cancer Melanoma Staging and Classification on dermatologists and their patients.
    Nading MA; Balch CM; Sober AJ
    Semin Cutan Med Surg; 2010 Sep; 29(3):142-7. PubMed ID: 21051007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interobserver variability of histopathological prognostic parameters in cutaneous malignant melanoma: impact on patient management.
    Eriksson H; Frohm-Nilsson M; Hedblad MA; Hellborg H; Kanter-Lewensohn L; Krawiec K; Lundh Rozell B; Månsson-Brahme E; Hansson J
    Acta Derm Venereol; 2013 Jul; 93(4):411-6. PubMed ID: 23306667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.